Changes in pro-inflammatory cytokine levels and late-life depression: A two year population based longitudinal study

[1]  Sophie E. Holmes,et al.  Elevated Translocator Protein in Anterior Cingulate in Major Depression and a Role for Inflammation in Suicidal Thinking: A Positron Emission Tomography Study , 2018, Biological Psychiatry.

[2]  Charles F. Reynolds,et al.  Management of Depression in Older Adults: A Review , 2017, JAMA.

[3]  A. Carvalho,et al.  Peripheral cytokine and chemokine alterations in depression: a meta‐analysis of 82 studies , 2017, Acta psychiatrica Scandinavica.

[4]  Proteesh Rana,et al.  Comparison of fluoxetine and 1-methyl-L-tryptophan in treatment of depression-like illness in Bacillus Calmette-Guerin-induced inflammatory model of depression in mice , 2016, Journal of basic and clinical physiology and pharmacology.

[5]  Young T. Hong,et al.  Neuroinflammatory and morphological changes in late-life depression: the NIMROD study , 2016, British Journal of Psychiatry.

[6]  Sung-Wan Kim,et al.  Associations of cytokine genes with Alzheimer's disease and depression in an elderly Korean population , 2014, Journal of Neurology, Neurosurgery & Psychiatry.

[7]  C. Mady,et al.  Plasma Cytokine Profile in Tropical Endomyocardial Fibrosis: Predominance of TNF-a, IL-4 and IL-10 , 2014, PloS one.

[8]  W. Taylor,et al.  The vascular depression hypothesis: mechanisms linking vascular disease with depression , 2013, Molecular Psychiatry.

[9]  P. Sachdev,et al.  Inflammatory biomarkers predict depressive, but not anxiety symptoms during aging: The prospective Sydney Memory and Aging Study , 2012, Psychoneuroendocrinology.

[10]  M. Maes,et al.  Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression , 2012, Neuroscience & Biobehavioral Reviews.

[11]  Michael Maes.  Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[12]  F. Licastro,et al.  Blood Inflammatory Proteins and Risk of Incident Depression in the Elderly , 2010, Dementia and Geriatric Cognitive Disorders.

[13]  T. Kamarck,et al.  A prospective evaluation of the directionality of the depression–inflammation relationship , 2009, Brain, Behavior, and Immunity.

[14]  S. Bandinelli,et al.  Interleukin-1 Receptor Antagonist and Incident Depressive Symptoms Over 6 Years in Older Persons: The InCHIANTI Study , 2009, Biological Psychiatry.

[15]  Shuran Li,et al.  Prevalence of dementia in Latin America, India, and China: a population-based cross-sectional survey , 2008, The Lancet.

[16]  R. Stewart,et al.  Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression , 2008, British Journal of Psychiatry.

[17]  A. Beekman,et al.  Inflammatory markers in late-life depression: results from a population-based study. , 2008, Journal of affective disorders.

[18]  David Loewenstein,et al.  Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. , 2006, Archives of general psychiatry.

[19]  Kenneth E Freedland,et al.  Depression, the Autonomic Nervous System, and Coronary Heart Disease , 2005, Psychosomatic medicine.

[20]  J. Gottdiener,et al.  The role of immune system parameters in the relationship between depression and coronary artery disease. , 2005, Psychosomatic medicine.

[21]  Karina W Davidson,et al.  The epidemiology, pathophysiology, and management of psychosocial risk factors in cardiac practice: the emerging field of behavioral cardiology. , 2005, Journal of the American College of Cardiology.

[22]  D. Posthuma,et al.  Heritability estimates of innate immunity: an extended twin study , 2005, Genes and Immunity.

[23]  R. Stewart,et al.  Physical health, depression and cognitive function as correlates of disability in an older Korean population , 2005, International journal of geriatric psychiatry.

[24]  M. Wichers,et al.  Cytokines and major depression , 2005, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[25]  Ruoling Chen,et al.  A community‐based study of depression in older people in Hefei, China—the GMS‐AGECAT prevalence, case validation and socio‐economic correlates , 2004, International journal of geriatric psychiatry.

[26]  L. Ferrucci,et al.  Inflammatory markers and depressed mood in older persons: results from the health, aging and body composition study , 2003, Biological Psychiatry.

[27]  R. Stewart,et al.  Diagnosing dementia in a developing nation: an evaluation of the GMS‐AGECAT algorithm in an older Korean population , 2003, International journal of geriatric psychiatry.

[28]  M. Prince,et al.  Dementia diagnosis in developing countries: a cross-cultural validation study , 2003, The Lancet.

[29]  R. Dantzer,et al.  Cytokine-induced sickness behaviour: mechanisms and implications , 2002, Trends in Neurosciences.

[30]  J. Maccluer,et al.  A population-based, cross-sectional survey of the Zuni Pueblo: a collaborative approach to an epidemic of kidney disease. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[31]  R. Dantzer.  Cytokine‐Induced Sickness Behavior: Mechanisms and Implications , 2001, Annals of the New York Academy of Sciences.

[32]  T. Tang,et al.  Community study of depression in old age in Taiwan , 2001, British Journal of Psychiatry.

[33]  P. Mottram,et al.  Validation of the Hamilton Depression Rating Scale and Montgommery and Asberg Rating Scales in terms of AGECAT depression cases , 2000, International journal of geriatric psychiatry.

[34]  M. Wong,et al.  The role of inflammatory mediators in the biology of major depression: central nervous system cytokines modulate the biological substrate of depressive symptoms, regulate stress-responsive systems, and contribute to neurotoxicity and neuroprotection , 1999, Molecular Psychiatry.

[35]  C. Nemeroff,et al.  Psychoneuroendocrinology of depression. Hypothalamic-pituitary-adrenal axis. , 1998, The Psychiatric clinics of North America.

[36]  E. Kua.  A Community Study of Mental Disorders in Elderly Singaporean Chinese Using the Gms-Agecat Package , 1992, The Australian and New Zealand journal of psychiatry.

[37]  J. Copeland,et al.  The epidemiology of dementia: GMS-AGECAT studies of prevalence and incidence, including studies in progress , 1991, European Archives of Psychiatry and Clinical Neuroscience.

[38]  J. Copeland,et al.  A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT , 1986, Psychological Medicine.

[39]  S. Folstein,et al.  "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. , 1975, Journal of psychiatric research.

[40]  R. Dantzer,et al.  From inflammation to sickness and depression: when the immune system subjugates the brain , 2008, Nature Reviews Neuroscience.

[41]  A. Hofman,et al.  Inflammatory proteins and depression in the elderly. , 2003, Epidemiology.

[42]  V. Leirer,et al.  Development and validation of a geriatric depression screening scale: a preliminary report. , 1982, Journal of psychiatric research.

[43]  L. Radloff.  The CES-D Scale: A Self-Report Depression Scale for Research in the General Population — Source link , 2022 .